ERCC1 and non-small cell lung carcinoma: Increased ERCC1 is correlated with platinum resistance in many cancers, including ovarian, nasopharyngeal, cervical, head and neck squamous carcinoma, lung adenocarcinoma, non-small cell lung cancer, and gastric cancer [174,178].